| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TOVX | Theriva Biologics, Inc. | SHALLCROSS STEVEN A | CEO and CFO | Jun 07, 2023 | Buy | $0.69 | 14,000 | 9,703 | 250,000 | Jun 08, 2023, 07:00 AM | |
| TOVX | Theriva Biologics, Inc. | SHALLCROSS STEVEN A | CEO and CFO | Jun 06, 2023 | Buy | $0.63 | 26,000 | 16,453 | 236,000 | Jun 07, 2023, 07:00 AM | |
| ELYS | Elys Game Technology, Corp. | SHALLCROSS STEVEN A | Director | Feb 14, 2023 | Option Exercise | $0.89 | 22,472 | 20,000 | 27,717 | Feb 16, 2023, 06:39 PM | |
| TOVX | Theriva Biologics, Inc. | SHALLCROSS STEVEN A | CEO and CFO | Feb 10, 2023 | Buy | $1.04 | 25,000 | 26,075 | 210,000 | Feb 13, 2023, 06:06 AM | |
| TOVX | Theriva Biologics, Inc. | SHALLCROSS STEVEN A | CEO and CFO | Feb 02, 2023 | Buy | $0.94 | 25,000 | 23,513 | 185,000 | Feb 03, 2023, 06:02 AM | |
| TOVX | Theriva Biologics, Inc. | SHALLCROSS STEVEN A | CEO and CFO | Jan 25, 2023 | Buy | $0.87 | 25,000 | 21,825 | 160,000 | Jan 26, 2023, 06:03 AM | |
| TOVX | Theriva Biologics, Inc. | SHALLCROSS STEVEN A | CEO and CFO | Jan 20, 2023 | Buy | $0.75 | 25,000 | 18,705 | 135,000 | Jan 23, 2023, 06:08 AM | |
| TOVX | Theriva Biologics, Inc. | SHALLCROSS STEVEN A | CEO and CFO | Dec 29, 2022 | Buy | $0.44 | 100,000 | 43,700 | 110,000 | Jan 03, 2023, 06:04 AM | |
| SYN | Synthetic Biologics, Inc. | SHALLCROSS STEVEN A | CEO and CFO | May 10, 2021 | Buy | $0.49 | 50,000 | 24,595 | 100,000 | May 10, 2021, 05:30 PM | |
| NWGI | Elys Game Technology, Corp. | SHALLCROSS STEVEN A | Director | Jan 22, 2021 | Option Exercise | $5.72 | 5,245 | 30,001 | 5,245 | Jan 27, 2021, 10:25 AM | |
| SYN | Synthetic Biologics, Inc. | SHALLCROSS STEVEN A | CEO and CFO | Aug 23, 2019 | Buy | $0.42 | 50,000 | 20,785 | 50,000 | Aug 26, 2019, 05:00 PM | |
| CMXI | CYTOMEDIX INC | SHALLCROSS STEVEN A | Chief Financial Officer | Aug 26, 2014 | Buy | $0.38 | 27,500 | 10,450 | 79,500 | Aug 27, 2014, 06:13 AM | |
| CMXI | CYTOMEDIX INC | SHALLCROSS STEVEN A | Chief Financial Officer | Aug 20, 2014 | Buy | $0.39 | 52,000 | 20,280 | 52,000 | Aug 21, 2014, 05:16 PM |
Menu